期刊文献+

吡非尼酮的合成及结构确证 被引量:4

Synthesis and structural identification of Pirfenidone
下载PDF
导出
摘要 目的合成抗纤维化药物吡非尼酮。方法以2-氨基-5-甲基吡啶为原料,经重氮化水解为5-甲基-2(1H)-吡啶酮,再经N-芳基化反应得到吡非尼酮。结果合成的吡非尼酮经高分辨质谱、紫外吸收光谱、红外吸收光谱、核磁共振谱、质谱和热分析确证结构,总收率为49.0%,纯度≥99.9%。结论该合成工艺操作简便,收率高,纯度高,是合成吡非尼酮的较好方法。 Objective To synthesize Pirfenidone, a novel antifibrotic drug. Methods Pirfenidone was synthesized from 2-amino-5-methylpyridin,via diazotization,hydrolysis,N-phenylation. Results The structure of Pirfenidone was confirmed by ESI-MS,UV,IR, NMR,MS,DSC and TGA. The total yield was 49. 0% and the purity of Pirfenidone ≥99. 9%. Conclusions The method is a better process with simple procedure,good yield and high purity.
作者 郭成
出处 《安徽医药》 CAS 2014年第11期2051-2053,共3页 Anhui Medical and Pharmaceutical Journal
关键词 吡非尼酮 合成 结构确证 Pirfenidone synthesis structural identification
  • 相关文献

参考文献7

  • 1Okazaki A, Ohkura N,Fujimura M,et al. Effects of pirfenidone on increased cough reflex sensitivity in guinea pigs[J]. Pulm Pharma- col Ther,2013,26 ( 5 ) :603 - 608.
  • 2特发性肺纤维化治疗药吡非尼酮[J].药学进展,2010,34(12):572-574. 被引量:3
  • 3李丽,阳惠湘.吡非尼酮抗肝纤维化机制[J].国际病理科学与临床杂志,2010,30(3):220-225. 被引量:7
  • 4Jhon V. Substituted 1-m-aminophenyl-2-pyridones : US, 2947755 [P]. 1960 -08 -02.
  • 5Shreekrishna M. 5-Methyl-l-pbenyl-2-( 1 H) -pyndone compositions and methods of use:US ,3974281 [ P]. 1976 -08 - 10.
  • 6马臻,王尊元,沈正荣.吡非尼酮的合成[J].中国医药工业杂志,2006,37(6):372-373. 被引量:8
  • 7Thomas G. Substituted N-aryl-pyridones : US, 2008/0319026 [ P ]. 2008 - 12 - 25.

二级参考文献53

  • 1张晓岚,王占魁,姜慧卿.氧化应激与肝纤维化[J].临床肝胆病杂志,2007,23(3):226-229. 被引量:24
  • 2Bataller R,Brenner DA.Liver fibrosis[J].J Clin Invest,2005,115(2):209-218.
  • 3Ismail MH,Pinzani M.Reversal of liver fibrosis[J].Saudi J Gastroenterol,2009,15(1):72-79.
  • 4Al-Bayati MA,Xie Y,Mohr FC,et al.Effect of pirfenidone against vanadate-induced kidney fibrosis in rats[J].Biochem Pharmacol,2002,64(3):517-525.
  • 5Van Erp C,Irwin NG,Hoey AJ.Long-term administration of pirfenidone improves cardiac function in mdx mice[J].Muscle Nerve,2006,34(3):327-334.
  • 6Oku H,Shimizu T,Kawabata T,et al.Antifibrotic action of pirfenidone and prednisolone:different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis[J].Eur J Pharmacol,2008,590(1-3):400-408.
  • 7Grizzi F.Pirfenidone:a potential therapeutic option in the treatment of liver fibrosis[J].Clin Exp Pharmacol Physiol,2009,36(10):961-962.
  • 8Regulatory watch:First drug for idiopathic pulmonary fibrosis approved in Japan[J].Nat Rev Drug Discov,2008,7(12):966-967.
  • 9Lasky J.Pirfenidone[J].IDrugs,2004,7(2):166-172.
  • 10Iyer SN,Wild JS,Schiedt MJ,et al.Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters[J].J Lab Clin Med,1995,125(6):779-785.

共引文献15

同被引文献68

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部